VEURX | VEUVX | VEURX / VEUVX | |
Total Expense Ratio | 0.24 | 0.77 | 31% |
Annual Report Gross Expense Ratio | 0.24 | 0.77 | 31% |
Fund Existence | 35 years | 7 years | - |
Gain YTD | 21.695 | 28.755 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 15000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 32.4B | 600M | 5,400% |
Annual Yield % from dividends | 2.75 | 3.33 | 83% |
Returns for 1 year | 9.80 | 18.00 | 54% |
Returns for 3 years | 29.55 | 54.91 | 54% |
Returns for 5 years | 47.73 | 91.82 | 52% |
Returns for 10 years | 43.61 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FBT | 164.68 | 2.68 | +1.66% |
First Trust NYSE Arca Biotech ETF | |||
IWV | 340.96 | 3.69 | +1.09% |
iShares Russell 3000 ETF | |||
PEZ | 95.13 | 0.64 | +0.67% |
Invesco DW Consumer Cyclicals Momt ETF | |||
IBTM | 22.52 | -0.16 | -0.71% |
iShares iBonds Dec 2032 Term Trs ETF | |||
SMOG | 108.58 | -0.99 | -0.90% |
VanEck Low Carbon Energy ETF |